Sex steroid hormones in diabetes-induced sexual dysfunction: Focus on the female gender

Journal of Sexual Medicine

Volumn 6, Issue SUPPL. 3, 2009, Pages 239-246

  Kim, Noel N ^a  

^a Institute for Sexual Medicine   (United States)

Author keywords

Diabetes; Estrogen; Testosterone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; INSULIN; PRASTERONE; RALOXIFENE; SEX HORMONE; STREPTOZOCIN; TESTOSTERONE;

APOPTOSIS; CONFERENCE PAPER; DIABETES MELLITUS; DIABETOGENESIS; DRUG ACTIVITY; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONE METABOLISM; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; KIDNEY FIBROSIS; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PEER REVIEW; PRIORITY JOURNAL; SEXUAL FUNCTION;

EID: 61849137169     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.01182.x     Document Type: Conference Paper

References (88)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
2. Hakim LS, Goldstein I. Diabetic sexual dysfunction. Endocrinol Metab Clin North Am 1996; 25: 379-400.
3. Kaiser FE, Korenman SG. Impotence in diabetic men. Am J Med 1988; 85: 147-52.
4. Newman AS, Bertelson AD. Sexual dysfunction in diabetic women. J Behav Med 1986; 9: 261-70.
5. Campbell LV, Redelman MJ, Borkman M, McLay JG, Chisholm DJ. Factors in sexual dysfunction in diabetic female volunteer subjects. Med J Aust 1989; 151: 550-2.
6. Jensen SB. The natural history of sexual dysfunction in diabetic women. A 6-year follow-up study. Acta Med Scand 1986; 219: 73-8.
7. Schreiner-Engel P, Schiavi RC, Vietorisz D, Smith H. The differential impact of diabetes type on female sexuality. J Psychosom Res 1987; 31: 23-33.
8. Erol B, Tefekli A, Ozbey I, Salman F, Dincag N, Kadioglu A, Tellaloglu S. Sexual dysfunction in type II diabetic females: A comparative study. J Sex Marital Ther 2002; 28 (1 suppl): 55-62.
9. Erol B, Tefekli A, Sanli O, Ziylan O, Armagan A, Kendirci M, Eryasar D, Kadioglu A. Does sexual dysfunction correlate with deterioration of somatic sensory system in diabetic women? Int J Impot Res 2003; 15: 198-202.
10. Enzlin P, Mathieu C, Van den Bruel A, Bosteels J, Vanderschueren D, Demyttenaere K. Sexual dysfunction in women with type I diabetes: A controlled study. Diabetes Care 2002; 25: 672-7.
11. Doruk H, Akbay E, Cayan S, Akbay E, Bozlu M, Acar D. Effect of diabetes mellitus on female sexual function and risk factors. Arch Androl 2005; 51: 1-6.
12. Salonia A, Lanzi R, Scavini M, Pontillo M, Gatti E, Petrella G, Licata G, Nappi RE, Bosi E, Briganti A, Rigatti P, Montorsi F. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care 2006; 29: 312-6.
13. Sarkadi A, Rosenqvist U. Intimacy and women with type 2 diabetes: An exploratory study using focus group interviews. Diabetes Educ 2003; 29: 641-52.
14. Glintborg D, Henriksen JE, Andersen M, Hagen C, Hangaard J, Rasmussen PE, Schousboe K, Hermann AP. Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis. Fertil Steril 2004; 82: 1570-9.
15. Tok EC, Ertunc D, Evruke C, Dilek S. The androgenic profile of women with non-insulin-dependent diabetes mellitus. J Reprod Med 2004; 49: 746-52.
16. Lee CC, Kasa-Vubu JZ, Supiano MA. Androgenicity and obesity are independently associated with insulin sensitivity in postmenopausal women. Metabolism 2004; 53: 507-12.
17. Boyd-Woschinko G, Kushner H, Falkner B. Androgen excess is associated with insulin resistance and the development of diabetes in African American women. J Cardiometab Syndr 2007; 2: 254-9.
18. Ding EL, Song Y, Manson JE, Rifai N, Buring JE, Liu S. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: A prospective study. Diabetologia 2007; 50: 2076-84.
19. Goodman-Gruen D, Barrett-Connor E. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 2000; 23: 912-8.
20. Barrett-Connor E, Khaw KT, Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 1990; 132: 895-901.
21. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: Prospective results from the Massachusetts male aging study. Diabetes Care 2000; 23: 490-4.
22. Corona G, Mannucci E, Mansani R, Petrone L, Bartolini M, Giommi R, Forti G, Maggi M. Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus. Eur Urol 2004; 46: 222-8.
23. Corona G, Mannucci E, Petrone L, Ricca V, Balercia G, Mansani R, Chiarini V, Giommi R, Forti G, Maggi M. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res 2006; 18: 190-7.
24. Corona G, Mannucci E, Petrone L, Balercia G, Paggi F, Fisher AD, Lotti F, Chiarini V, Fedele D, Forti G, Maggi M. NCEP-ATPII I-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med 2007; 4: 1038-45.
25. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004; 27: 1036-41.
26. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2006; 295: 1288-99.
27. Jakobson T. Clinical studies on adrenocortical function in diabetes mellitus. Acta Endocrinol Suppl 1958; 29 (41 suppl): 1-83.
28. 4 -3-ketosteroid reductase activity. J Biol Chem 1963; 238: 2923-5.
29. Gold NI, Garren LD. Effect of experimental diabetes on steroid metabolism. II. Alterations in androst-4-ene-3,17-dione and cortisol metabolism. J Biol Chem 1964; 239: 2796-803.
30. Landon J, Wynn V, Samols E. The effect of anabolic steroids on blood sugar and plasma insulin levels in man. Metabolism 1963; 12: 924-35.
31. Saskin E, Waldman S, Pelner L. Diabetic retinopathy. A new approach to therapy with a steroid hormone-testosterone propionate. Am J Ophthalmol 1951; 34: 613-7.
32. Gurling KJ. Evaluation of an androgen, methylandrostenediol, in the treatment of diabetic retinopathy. Br J Ophthalmol 1955; 39: 151-4.
33. Szpunar WE, Blair AJ Jr, McCann DS. Plasma androgen concentrations in diabetic women. Diabetes 1977; 26: 1125-9.
34. Andersson B, Mårin P, Lissner L, Vermeulen A, Björntorp P. Testosterone concentrations in women and men with NIDDM. Diabetes Care 1994; 17: 405-11.
35. Kapoor D, Clarke S, Stanworth R, Channer KS, Jones TH. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2007; 156: 595-602.
36. Malkin CJ, Jones TH, Channer KS. The effect of testosterone on insulin sensitivity in men with heart failure. Eur J Heart Fail 2007; 9: 44-50.
37. Naharci MI, Pinar M, Bolu E, Olgun A. Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism. Endocr Pract 2007; 13: 629-35.
38. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 2003; 6: 1-7.
39. Thunell L, Andersson B, Glassell M, Mattsson LA. The effect of continuous combined HRT on glucose homeostatsis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes. Maturitas 2006; 53: 430-8.
40. Andersson B, Mattsson LA, Hahn L, Mårin P, Lapidus L, Holm G, Bengtsson BA, Björntorp P. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmeopausal women with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 638-43.
41. Samaras K, Hayward CS, Sullivan D, Kelly RP, Campbell LV. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: A prospective study. Diabetes Care 1999; 22: 1401-7.
42. Sandoval DA, Ertl AC, Richardson MA, Tate DB, Davis SN. Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia. Diabetes 2003; 52: 1749-55.
43. Dhatariya K, Bigelow ML, Nair KS. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes 2005; 54: 765-9.
44. Ding D, Xu L, Menon M, Reddy GP, Barrack ER. Effect of a short CAG (glutamine) repeat on human androgen receptor function. Prostate 2004; 58: 23-32.
45. Möhlig M, Jürgens A, Spranger J, Hoffmann K, Weickert MO, Schlösser HW, Schill T, Brabant G, Schüring A, Pfeiffer AF, Gromoll J, Schöfl C. The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome. Eur J Endocrinol 2006; 155: 127-30.
46. Paik SG, Michelis MA, Kim YT, Shin S. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens. Diabetes 1982; 31: 724-9.
47. Kromann H, Christy M, Lernmark A, Nedergaard M, Nerup J. The low dose streptozotocin murine model of type 1 (insulin-dependent) diabetes mellitus: Studies in vivo and in vitro of the modulating effect of sex hormones. Diabetologia 1982; 22: 194-8.
48. Rosmalen JG, Pigmans MJ, Kersseboom R, Drexhage HA, Leenen PJ, Homo-Delarche F. Sex steroids influence pancreatic islet hypertrophy and subsequent autoimmune infiltration in nonobese diabetic (NOD) and NODscid mice. Lab Invest 2001; 81: 231-9.
49. Fox HS. Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med 1992; 175: 1409-12.
50. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc Natl Acad Sci USA 2000; 97: 12729-34.
51. Lin HY, Xu Q, Yeh S, Wang RS, Sparks JD, Chang C. Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 2005; 54: 1717-25.
52. Derweesh IH, Diblasio CJ, Kincade MC, Malcolm JB, Lamar KD, Patterson AL, Kitabchi AE, Wake RW. Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate cancer. BJU Int 2007; 100: 1060-5.
53. Basaria S, Muller DC, Carducci MA, Egan J, Dobs AS. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 2006; 106: 581-8.
54. Lage MJ, Barber BL, Markus RA. Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer. Urology 2007; 70: 1104-8.
55. Senöz S, Direm B, Gülekli B, Gökmen O. Estrogen deprivation, rather than age, is responsible for the poor lipid profile and carbohydrate metabolism in women. Maturitas 1996; 25: 107-14.
56. Otsuki M, Kasayama S, Morita S, Asanuma N, Saito H, Mukai M, Koga M. Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women. Menopause 2007; 14: 404-7.
57. Thliveris JA, Paz GF, Rempel E, Faiman C. An extra-pancreatic direct effect of streptozotocin on the hypothalamo-hypophyseal-testicular axis in the rat. Ann Anat 1984; 157: 213-9.
58. Rossi GL, Bestetti G. Morphological changes in the hypothalamic-hypophyseal-gonadal axis of male rats after twelve months of streptozotocin-induced diabetes. Diabetologia 1981; 21: 476-81.
59. Pérez Díaz J, Benitez A, Fernández Galaz C. Effect of streptozotocin diabetes on the pituitary-testicular axis in the rat. Horm Metab Res 1982; 14: 479-82.
60. Garzo VG, Dorrington JH. Aromatase activity in human granulosa cells during follicular development and the modulation by follicle-stimulating hormone and insulin. Am J Obstet Gynecol 1984; 148: 657-62.
61. Nestler JE, Strauss JF. Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am 1991; 20: 807-23.
62. Madsbad S, Gluud C, Bennett P, Krarup T. Rapid changes in plasma androgens during insulin withdrawal in male type 1 (insulin-dependent) diabetics. J Endocrinol Invest 1986; 9: 21-5.
63. Zhu M, Mizuno A, Kuwajima M, Ogino T, Murakami T, Noma Y, Sano T, Shima K. Ovarian hormone-induced beta-cell hypertrophy contributes to the homeostatic control of beta-cell mass in OLETF female rat, a model of type II diabetes. Diabetologia 1998; 41: 799-805.
64. Le May C, Chu K, Hu M, Ortega CS, Simpson ER, Korach KS, Tsai MJ, Mauvais-Jarvis F. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 2006; 103: 9232-7.
65. Barros RP, Machado UF, Warner M, Gustafsson JA. Muscle GLUT4 regulation by estrogen receptors ERβ and ERα. Proc Natl Acad Sci USA 2006; 103: 1605-8.
66. Rangwala SM, Li X, Lindsley L, Wang X, Shaughnessy S, Daniels TG, Szustakowski J, Nirmala NR, Wu Z, Stevenson SC. Estrogen-related receptor alpha is essential for the expression of antioxidant protection genes and mitochondrial function. Biochem Biophys Res Commun 2007; 357: 231-6.
67. Mankhey RW, Bhatti F, Maric C. 17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol 2005; 288: F399-405.
68. Maric C, Sandberg K, Hinojosa-Laborde C. Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. J Am Soc Nephrol 2004; 15: 1546-56.
69. Mankhey RW, Wells CC, Bhatti F, Maric C. 17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am J Physiol Regul Integr Comp Physiol 2007; 292: R769-77.
70. Wells CC, Riazi S, Mankhey RW, Bhatti F, Ecelbarger C, Maric C. Diabetic nephropathy is associated with decreased circulating estradiol levels and imbalance in the expression of renal estrogen receptors. Gend Med 2005; 2: 227-37.
71. Dixon A, Maric C. 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. Am J Physiol Renal Physiol 2007; 293: F1678-90.
72. Riazi S, Maric C, Ecelbarger CA. 17-beta Estradiol attenuates streptozotocin-induced diabetes and regulates the expression of renal sodium transporters. Kidney Int 2006; 69: 471-80.
73. Dixon A, Wells CC, Singh S, Babayan R, Maric C. Renoprotective effects of a selective estrogen receptor modulator, raloxifene, in an animal model of diabetic nephropathy. Am J Nephrol 2007; 27: 120-8.
74. Siegel LI, Wade GN. Insulin withdrawal impairs sexual receptivity and retention of brain cell nuclear estrogen receptors in diabetic rats. Neuroendocrinology 1979; 29: 200-6.
75. Ahdieh HB, Hamilton JM, Wade GN. Copulatory behavior and hypothalamic estrogen and progestin receptors in chronically insulin-deficient female rats. Physiol Behav 1983; 31: 219-23.
76. Park K, Ahn K, Chang JS, Lee SE, Ryu SB, Park YI. Diabetes induced alteration of clitoral hemodynamics and structure in the rabbit. J Urol 2002; 168: 1269-72.
77. Park JK, Lee SO, Cui WS, Kim SZ, Koh GY, Cho KW. Activity of angiotensin peptides in clitoral cavernosum of alloxan induced diabetic rabbit. Eur Urol 2005; 48: 1042-50.
78. Giraldi A, Persson K, Werkström V, Alm P, Wagner G, Andersson KE. Effects of diabetes on neurotransmission in rat vaginal smooth muscle. Int J Impot Res 2001; 13: 58-66.
79. Park K, Ryu SB, Park YI, Ahn K, Lee SN, Nam JH. Diabetes mellitus induces vaginal tissue fibrosis by TGF-beta 1 expression in the rat model. J Sex Marital Ther 2001; 27: 577-87.
80. Ferrini MG, Nolazco G, Vernet D, Gonzalez-Cadavid NF, Berman J. Increased vaginal oxidative stress, apoptosis, and inducible nitric oxide synthase in a diabetic rat model: Implications for vaginal fibrosis. Fertil Steril 2006; 86 (4 suppl): 1152-63.
81. Ozawa S, Iguchi T, Takemura KK, Bern HA. Effect of certain growth factors on proliferation in serum-free collagen gel culture of vaginal epithelial cells from prepuberal mice exposed neonatally to diethylstilbestrol. Proc Soc Exp Biol Med 1991; 198: 760-3.
82. Suzuki A, Urushitani H, Watanabe H, Sato T, Iguchi T, Kobayashi T, Ohta Y. Comparison of estrogen responsive genes in the mouse uterus, vagina and mammary gland. J Vet Med Sci 2007; 69: 725-31.
83. Kim NN, Stankovic M, Cushman TT, Goldstein I, Munarriz R, Traish AM. Streptozotocin-induced diabetes in the rat is associated with changes in vaginal hemodynamics, morphology and biochemical markers. BMC Physiol 2006; 6: 4.
84. Traish AM, Kim SW, Stankovic M, Goldstein I, Kim NN. Testosterone increases blood flow and expression of androgen and estrogen receptors in the rat vagina. J Sex Med 2007; 4: 609-19.
85. Kim SW, Kim NN, Jeong SJ, Munarriz R, Goldstein I, Traish AM. Modulation of rat vaginal blood flow and estrogen receptor by estradiol. J Urol 2004; 172: 1538-43.
86. Pessina MA, Hoyt RF Jr, Goldstein I, Traish AM. Differential regulation of the expression of the estrogen, progesterone, and androgen receptors by sex steroid hormones in the vagina: Immunohistochemical studies. J Sex Med 2006; 3: 804-14.
87. Hummel KP, Dickie MM, Coleman DL. Diabetes, a new mutation in the mouse. Science 1966; 153: 1127-8.
88. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.